Global Axial Spondyloarthritis Market to Reach USD 8.79 Billion by 2030 Amid Advancements in Treatment Modalities and Drug Classes
February 26, 2024 17:25 ET
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis Market by Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA))), Drug Class...
Global Ankylosing Spondylitis Market is Projected to Reach $7.29 Billion by 2027: Leading Players Pfizer, AbbVie, and Novartis Drive Advances in Treatment Options
October 12, 2023 07:03 ET
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Ankylosing Spondylitis Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global ankylosing spondylitis...